Bio-Rad Laboratories, Inc.: how funds voted at the meeting of 21 Apr 2026
- Ticker
- BIO
- Meeting
- Season
- year to 30 June 2026
- Filers reporting
- 594
- Ballot items
- 5
594 filers on Form N-PX reported votes at the Bio-Rad Laboratories, Inc. meeting of 21 Apr 2026. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2026. Filings read through . How the figures are made
The ballot
Item 1: Director elections
2 nominees. 73.0% of the reported votes are for. 56 filers withheld from or voted against at least one nominee.
784 vote records from 182 filers. 42 of the 180 filers that marked the item voted against management. 2 filers gave no management mark.
- Positions of 44 fund families
- For 35
- Against 9
- Against management 9
Item 2: Advisory vote on executive pay (say-on-pay)
920 vote records from 589 filers. 54 of the 562 filers that marked the item voted against management. 27 filers gave no management mark.
- Positions of 48 fund families
- For 43
- Against 5
- Against management 5
Item 3: Audit-related items (auditor ratification)
391 vote records from 182 filers. 2 of the 180 filers that marked the item voted against management. 2 filers gave no management mark.
- Positions of 44 fund families
- For 44
Item 4: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
418 vote records from 188 filers. 2 of the 185 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 44 fund families
- For 44
Item 5: Stockholder proposal regarding dual class capital structure.
388 vote records from 179 filers. 165 of the 177 filers that marked the item voted against management. 2 filers gave no management mark.
- Positions of 44 fund families
- For 44
- Against management 43
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Auditor | 5. Proposal |
|---|---|---|---|
| AllianceBernstein | For | No report | No report |
| Allspring | For | For | For, against management |
| American Century | For | For | For, against management |
| Baird | For | No report | No report |
| BlackRock and iShares | For | For | For, against management |
| BNY Mellon | Against, against management | For | For, against management |
| Brighthouse Funds | For | For | For, against management |
| Capital Group and American Funds | Against, against management | For | For, against management |
| Charles Schwab | For | For | For, against management |
| Columbia Threadneedle | For | For | For, against management |
| Dimensional | For | For | For, against management |
| DWS | For | No report | No report |
| Equitable | For | For | For, against management |
| Federated Hermes | For | For | For, against management |
| Fidelity | For | For | For, against management |
| First Trust | For | For | For |
| Franklin Templeton | For | For | For, against management |
| Goldman Sachs | For | For | For, against management |
| Guggenheim and Rydex | For | For | For, against management |
| Harbor Funds | For | For | For, against management |
| Invesco | Against, against management | For | For, against management |
| J.P. Morgan | For | For | For, against management |
| Jackson National funds | Against, against management | For | For, against management |
| John Hancock and Manulife | For | For | For, against management |
| Lincoln Financial | For | For | For, against management |
| MassMutual | For | For | For, against management |
| MFS | For | For | For, against management |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For, against management |
| Nationwide | For | For | For, against management |
| Natixis and Loomis Sayles | For | For | For, against management |
| Neuberger Berman | For | No report | No report |
| Northern Trust and FlexShares | For | For | For, against management |
| Nuveen and TIAA | For | For | For, against management |
| Pacific Life funds | For | For | For, against management |
| PGIM and Prudential | For | For | For, against management |
| PIMCO | For | For | For, against management |
| Principal | For | For | For, against management |
| ProShares and ProFunds | For | For | For, against management |
| Russell Investments | For | For | For, against management |
| SEI | For | For | For, against management |
| State Street and SPDR | For | For | For, against management |
| T. Rowe Price | For | For | For, against management |
| Thrivent | For | For | For, against management |
| Transamerica | For | For | For, against management |
| Vanguard | For | For | For, against management |
| Victory Capital | For | For | For, against management |
| Voya | For | For | For, against management |
| WisdomTree | Against, against management | For | For, against management |
Questions
- How many filers reported votes at the Bio-Rad Laboratories, Inc. meeting?
- 594 Form N-PX filers reported votes at the meeting of 21 Apr 2026. On say-on-pay, 54 of 562 filers that marked the item voted against management (9.6%). The filings show one separate proposal from security holders.
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Bio-Rad Laboratories, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Bio-Rad Laboratories, Inc. with a meeting date within three days of 21 Apr 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .